Giromini Andrew P, Salvatore Sonia R, Maxwell Brooke A, Lewis Sara E, Gunther Michael R, Fazzari Marco, Schopfer Francisco J, Leonardi Roberta, Kelley Eric E
West Virginia University Departments of Biochemistry and Molecular Medicine, Morgantown, WV, USA.
University of Pittsburgh, Department of Pharmacology and Chemical Biology, Pittsburgh, PA, USA.
Gout Urate Cryst Depos Dis. 2024 Sep;2(3):252-265. doi: 10.3390/gucdd2030019. Epub 2024 Aug 30.
Many preclinical reports have coalesced to identify a strong association between obesity and increased levels of uric acid (UA) in tissues and, importantly in the circulation (hyperuricemia). Unfortunately, nearly all these studies were conducted with male mice or, in one case, female mice without a side-by-side male cohort. Therefore, the relationship between obesity and hyperuricemia in female mice remains undefined. This lack of clarity in the field has considerable impact as the downstream effects of obesity and allied hyperuricemia are extensive, resulting in many comorbidities including cardiovascular dysfunction, chronic kidney disease and nonalcoholic fatty liver disease (NAFLD). Herein we begin to address this issue by revealing phenotypic and metabolic responses to diet-induced obesity (DIO) in a side-by-side male vs. female C57BL/6J study. Beginning at 6 weeks of age, mice were exposed to either an obesogenic diet (60% calories from fat) or control diet (10% calories from fat) for 19 weeks. Similar to numerous reported observations with the 60% diet, male mice experienced significant weight gain over time, elevated fasting blood glucose, impaired glucose tolerance and significantly elevated circulating uric acid levels (2.54 ± 0.33 mg/dL) compared to age-matched lean male controls (1.53 ± 0.19 mg/dL). As expected, the female mice experienced a slower rate of weight gain compared to the males; however, they also developed elevated fasting blood glucose and impaired glucose tolerance compared to age-matched lean controls. Countervailing our previous report whereby the control diet for the female-only study was vivarium standard chow (18% calories from fat), the obese female mice did demonstrate significantly elevated circulating UA levels (2.55 ± 0.15 mg/dL) compared to the proper control (1.68 ± 0.12 mg/dL). This affirms that the choice of control diet is crucial for reaching durable conclusions. , these results, for the first time, reveal elevated circulating UA to be a similar long-term response to obesogenic feeding for both males and females and mirrors clinical observations demonstrating hyperuricemia in obesity for both sexes.
许多临床前报告汇总后发现,肥胖与组织中尿酸(UA)水平升高之间存在密切关联,重要的是在循环系统中(高尿酸血症)也存在这种关联。不幸的是,几乎所有这些研究都是用雄性小鼠进行的,或者在一个案例中,是用没有并行雄性队列的雌性小鼠进行的。因此,雌性小鼠中肥胖与高尿酸血症之间的关系仍不明确。由于肥胖和相关高尿酸血症的下游影响广泛,会导致包括心血管功能障碍、慢性肾病和非酒精性脂肪性肝病(NAFLD)在内的许多合并症,该领域的这种不明确性具有相当大的影响。在此,我们通过在并行的雄性与雌性C57BL/6J研究中揭示对饮食诱导肥胖(DIO)的表型和代谢反应,开始解决这个问题。从6周龄开始,将小鼠暴露于致肥胖饮食(60%的热量来自脂肪)或对照饮食(10%的热量来自脂肪)中19周。与众多关于60%脂肪饮食的报道观察结果相似,随着时间的推移,雄性小鼠体重显著增加,空腹血糖升高,糖耐量受损,与年龄匹配的瘦雄性对照(1.53±±0.1mg/dL)相比,循环尿酸水平显著升高(2.54±±0.3mg/dL)。正如预期的那样,与雄性小鼠相比,雌性小鼠体重增加的速度较慢;然而,与年龄匹配的瘦对照相比,它们也出现了空腹血糖升高和糖耐量受损的情况。与我们之前的报告相反,在仅针对雌性的研究中,对照饮食是动物饲养室标准饲料(18%的热量来自脂肪),肥胖雌性小鼠与合适的对照(1.68±±0.1mg/dL)相比,确实表现出循环UA水平显著升高(2.55±±0.1mg/dL)。这证实了对照饮食的选择对于得出可靠结论至关重要。这些结果首次揭示,循环UA升高是雄性和雌性对致肥胖喂养的类似长期反应,这与临床观察结果一致,即肥胖的男性和女性都会出现高尿酸血症。